Telaah Potensi Interaksi Obat Resep Polifarmasi Klinik Jantung pada Salah Satu Rumah Sakit di Bandung
Isi Artikel Utama
Charlesworth, C. J. et al. (2015) ‘Polypharmacy among adults aged 65 years and older in the United States: 1988-2010’, Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 70(8), pp. 989–995. doi: 10.1093/gerona/glv013.
Dipiro, J. T. et al. (2017) Pharmacotherapy: A Pathophysiologic Approach. United States of America: McGraw-Hill Education.
Drugs Interaction Checker. (2020) diakses 10 Mei 2020 dari https://www.drugs.com/drug_interactions. html
Dunn, S. P., Holmes, D. R. and Moliterno, D. J. (2012) ‘Drug-drug interactions in cardiovascular catheterizations and interventions’, JACC: Cardiovascular Interventions. Elsevier Inc., 5(12), pp. 1195–1208. doi: 10.1016/j.jcin.2012.10.005.
Fajriansyah, Tahir, H. and Kombong, A. (2016) ‘Kajian Drug Relation Problem (DRPs) Kategori Interaksi Obat, Over Dosis dan Dosis Subterapi pada Pasien Gagal Jantung Kongestif di RSUP Universitas Hasanuddin’, Jurnal Ilmiah Farmasi, 5(1), pp. 91–102.
Hakkarainen, K. M. et al. (2012) ‘Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions –’, 7(3), pp. 11–13. doi: 10.1371/journal.pone.0033236.
Iyer, S. V et al. (no date) ‘Learning Signals of Adverse Drug-Drug Interactions from the Unstructured Text of Electronic Health Records’, 23, pp. 83–87.
Kementrian Kesehatan Republik Indonesia. (2019) Petunjuk Teknis Standar Pelayanan Kefarmasian di Rumah Sakit. Jakarta: Kementrian Kesehatan RI.
Lenander, C. et al. (2014) ‘Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates : a randomized controlled trial’, (August 2013), pp. 180–186. doi: 10.3109/02813432.2014.972062.
Maher Jr., R. L., Hanlon, J. T., and Hajjar, E. R. (2014) 'CLinical Consequnces of Polypharmacy in Elderly', Expert Opinion Drug Safetty, 13(1). doi: 10.1517/14740338/2013.827660.
Mateti, U. V. et al. (2011) ‘Drug-drug interactions in hospitalized cardiac patients’, Journal of Young MPharmacists, 3(4), pp. 329–333. doi: 10.4103/0975-1483.90246.
Medscape Drug Interaction Checker. (2020) diakses 10 Mei 2020 dari https://reference.medscape.com/ drug-interactionchecker
Pirmohamed, M. et al. (2004) ‘Adverse drug reactions as cause of admission to hospital ’:, 329(July), pp. 15–19.
Pusat Informasi Obat Nasional BPOM RI. (2020) diakses 12 April 2020 dari http://pionas.pom.go.id/ ioni/lampiran-1-interaksi-obat-0
Rama, M. et al. (2012) 'Assessment of Drug-Drug Interactions among Renal Failure Patients of Nephrology Ward in a South Indian Tertiary Care Hospital', Indian Journal of Pharmaceutical Sciences, 74(1), pp. 63-68. doi: 10.4103/0250-474X.102545.
Solberg, L. I. et al. (2020) ‘Measuring Patient Safety in Ambulatory Care : Potential for Identifying Medical Group Drug " Drug Interaction Rates Using Claims Data’, 10(2004), pp. 1–8.
Stockley, I. H. (2008) ‘Stockley ’s Drug Interactions’, Pharmaceutical Press. doi: 10.1345/aph.1G691.
Sulistiyowatiningsih, E., Nurul Hidayati, S. and Febrianti, Y. (2016) ‘Kajian Interaksi Obat Pada Pasien Gagal Jantung Dengan Gangguan Fungsi Ginjal Di Instalasi Rawat Inap Rsup Dr. Sardjito Yogyakarta Periode 2009-2013’, Jurnal Ilmiah Farmasi, 12(1), pp. 35–43. doi: 10.20885/jif.vol12.iss1.art4.
Zhou, Y. T. et al. (2014) ‘Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: Factors determining interaction strength and relevant clinical risk management’, Therapeutics and Clinical Risk Management, 10(1), pp. 17–26. doi: 10.2147/TCRM.S55512.
Zukkoor, S. and Thohan, V. (2020) ‘Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents’, pp. 1–8.
